Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The ...

EKF Diagnostics, the global in vitro diagnostics company, has announced the successful evaluation of its Quo-Lab® point-of-care HbA1c analyzer by the European Reference Laboratory for Glycohemoglobin.

Swansea University, College of Medicine, presents scientific poster at IDF 2013 Glycated hemoglobin (HbA1c) is widely used as a means of monitoring diabetes control and has recently been recommended ...

EKF Diagnostics Holdings plc (AIM: EKF), a worldwide manufacturer of point of care in-vitro diagnostic devices, announces that its new Quo-Lab HbA1c analyser has received CE marking allowing the ...

EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted point-of-care business, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V., part of Tosoh Corporation, the ...

Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more ...

The Hba1c Testing Device Market encompasses laboratory analyzers and point-of-care systems used to measure glycated hemoglobin (HbA1c), a gold-standard indicator of long-term glycemic control. These ...

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...